The present study demonstrates pDNA complexes of recombinant silk proteins containing poly(L-lysine) and tumor-homing peptides (THPs), which are globular and approximately 150-250 nm in diameter, show significant enhancement of target specificity to tumor cells by additions of F3 and CGKRK THPs. We report herein the preparation and study of novel nanoscale silk-based ionic complexes containing pDNA able to home specifically to tumor cells. Particular focus was on how the THP, F3 (KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK), and CGKRK, enhanced transfection specificity to tumor cells. Genetically engineered silk proteins containing both poly(L-lysine) domains to interact with pDNA and the THP to bind to specific tumor cells for target-specific pDNA delivery were prepared using Escherichia coli, followed by in vitro and in vivo transfection experiments into MDA-MB-435 melanoma cells and highly metastatic human breast tumor MDA-MB-231 cells. Non-tumorigenic MCF-10A breast epithelial cells were used as a control cell line for in vitro tumor-specific delivery studies. These results demonstrate that combination of the bioengineered silk delivery systems and THP can serve as a versatile and useful new platform for nonviral gene delivery.
The present study demonstrates pDNA complexes of recombinant silk proteins containing n class="Chemical">poly(L-lysine) and n class="Disease">tumor-homing peptides (THPs), which are globular and approximately 150-250 nm in diameter, show significant enhancement of target specificity to tumor cells by additions of F3 and CGKRK THPs. We report herein the preparation and study of novel nanoscale silk-based ionic complexes containing pDNA able to home specifically to tumor cells. Particular focus was on how the THP, F3 (KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK), and CGKRK, enhanced transfection specificity to tumor cells. Genetically engineered silk proteins containing both poly(L-lysine) domains to interact with pDNA and the THP to bind to specific tumor cells for target-specific pDNA delivery were prepared using Escherichia coli, followed by in vitro and in vivo transfection experiments into MDA-MB-435melanoma cells and highly metastatic humanbreast tumorMDA-MB-231 cells. Non-tumorigenic MCF-10A breast epithelial cells were used as a control cell line for in vitro tumor-specific delivery studies. These results demonstrate that combination of the bioengineered silk delivery systems and THP can serve as a versatile and useful new platform for nonviral gene delivery.
Authors: Gregory H Altman; Frank Diaz; Caroline Jakuba; Tara Calabro; Rebecca L Horan; Jingsong Chen; Helen Lu; John Richmond; David L Kaplan Journal: Biomaterials Date: 2003-02 Impact factor: 12.479
Authors: Kimmo Porkka; Pirjo Laakkonen; Jason A Hoffman; Michele Bernasconi; Erkki Ruoslahti Journal: Proc Natl Acad Sci U S A Date: 2002-05-28 Impact factor: 11.205
Authors: Jason A Hoffman; Enrico Giraudo; Mallika Singh; Lianglin Zhang; Masahiro Inoue; Kimmo Porkka; Douglas Hanahan; Erkki Ruoslahti Journal: Cancer Cell Date: 2003-11 Impact factor: 31.743
Authors: Sven Christian; Jan Pilch; Maria E Akerman; Kimmo Porkka; Pirjo Laakkonen; Erkki Ruoslahti Journal: J Cell Biol Date: 2003-11-24 Impact factor: 10.539
Authors: Olena S Tokareva; Dean L Glettig; Rosalyn D Abbott; David L Kaplan Journal: J Biomed Mater Res B Appl Biomater Date: 2014-11-17 Impact factor: 3.368
Authors: Katarzyna Jastrzebska; Kamil Kucharczyk; Anna Florczak; Ewelina Dondajewska; Andrzej Mackiewicz; Hanna Dams-Kozlowska Journal: Rep Pract Oncol Radiother Date: 2014-12-18
Authors: Anna Karolina Kozlowska; Anna Florczak; Maciej Smialek; Ewelina Dondajewska; Andrzej Mackiewicz; Marcin Kortylewski; Hanna Dams-Kozlowska Journal: Acta Biomater Date: 2017-07-08 Impact factor: 8.947